epirubicin has been researched along with Cholangitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baba, H; Beppu, T; Fujiyama, S; Haraoka, K; Komori, H; Okabe, K; Ouchida, Y; Sano, O; Yamanaka, T | 1 |
1 other study(ies) available for epirubicin and Cholangitis
Article | Year |
---|---|
[Postoperative cholangitis of balloon-occluded transarterial chemoembolization (B-TACE) for hepatocellular carcinoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangitis; Cisplatin; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Postoperative Complications | 2014 |